A new approach on stress-related depression & anxiety: Neuro-Psycho-Physical-Optimization with Radio Electric Asymmetric-Conveyer

Rinaldi Fontani Institute, Florence, Italy.
The Indian Journal of Medical Research (Impact Factor: 1.4). 08/2010; 132(8):189-94.
Source: PubMed


Chronic social stress is an important factor responsible for the worsening of depressive disorders in humans. In this study we present the relational Neuro-Psycho-Physical Optimization (NPPO) with Radio Electric Asymmetric Conveyer (REAC-CRM) as the treatment to tackle the unconscious dysfunction adjustments carried out by the central nervous system as a response to environmental stresses.
Psychological stress was measured in a group of 888 patients using the Psychological Stress Measure (PSM) test, a self-administered questionnaire. Data were collected immediately before and after the 4-wk therapy cycle. The detection of anxiety and depression clusters by PSM test has been based on the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR, APA, 2000) criteria. Six hundred and eighty eight patients (212 males, 476 females, average PSM test total scores 107.9 +/- 23.13) were treated with REAC-CRM therapy; 200 (64 males, 136 females, average PSM test total scores 107.86 +/- 25.80) were treated with "placebo REAC-CRM therapy"and used as control.
This study showed a significant reduction in scores measuring subjective perceptions of stress in the patients treated with a cycle of REAC-CRM therapy. At the end-point the number of patients reporting symptoms of stress-related anxiety and depression on the PSM test was significantly reduced (P<0.001); in the placebo group no significant difference was highlighted.
NPPO therapy with a cycle of REAC-CRM was shown to reduce subjective perceptions of stress measured by the PSM test and in particular, symptoms of stress-related anxiety and depression.

Download full-text


Available from: Salvatore Rinaldi
  • Source
    • "The REAC technology has two main fields of application, neuromodulation and biomodulation. In the context of neuromodulation specific REAC treatments have proven to be effective in treating various neuropsychiatric disorders131415161718192021. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this randomized double-blind study was to evaluate in healthy adult subjects, with functional magnetic resonance imaging (fMRI), long lasting changes in brain activation patterns following administration of a single, 250 milliseconds pulse emitted with radio-electric asymmetric conveyer (REAC) technology in the Wi-Fi bands. The REAC impulse was not administered during the scan, but after this, according to a protocol that has previously been demonstrated to be effective in improving motor control and postural balance, in healthy subjects and patients. The study was conducted on 33 healthy volunteers, performed with a 1.5 T unit while operating a motor block task involving cyclical and alternating flexion and extension of one leg. Subsequently subjects were randomly divided into a treatment and a sham treatment control group. Repeated fMRI examinations were performed following the administration of the REAC pulse or sham treatment. The Treated group showed cerebellar and ponto-mesencephalic activation components that disappeared in the second scan, while these activation components persisted in the Sham group. This study shows that a very weak signal, such as 250 milliseconds Wi-Fi pulse, administered with REAC technology, could lead to lasting effects on brain activity modification.
    Full-text · Article · Jul 2014 · Scientific Reports
  • Source
    • "As with other effects of Wi-Fi that have been reported in single studies, this study needs to be repeated with a standard exposure system and with blinding and sham-exposed controls. The same group has published a variety of other studies involving the ''Radioelectric Asymmetric Conveyer'' device (which members of the group developed and are promoting commercially), with endpoints as diverse as depression in humans and fertility in stallions (Rinaldi et al. 2010; Collodel et al. 2012). Some publications from this group identify the RF energy used in the studies as ''RF waves from Wi-Fi,'' and the device has output characteristics reminiscent of a Wi-Fi access point (although more recent papers mention output at 10.5 GHz as well). "
    [Show abstract] [Hide abstract]
    ABSTRACT: This review summarizes the current state of research on possible health effects of Wi-Fi (a commercial name for IEEE 802.11-compliant wireless networking). In response to public concerns about health effects of Wi-Fi and wireless networks and calls by government agencies for research on possible health and safety issues with the technology, a considerable amount of technology-specific research has been completed. A series of high quality engineering studies have provided a good, but not complete, understanding of the levels of radiofrequency (RF) exposure to individuals from Wi-Fi. The limited number of technology-specific bioeffects studies done to date are very mixed in terms of quality and outcome. Unequivocally, the RF exposures from Wi-Fi and wireless networks are far below U.S. and international exposure limits for RF energy. While several studies report biological effects due to Wi-Fi-type exposures, technical limitations prevent drawing conclusions from them about possible health risks of the technology. The review concludes with suggestions for future research on the topic.
    Full-text · Article · Dec 2013 · Health physics
  • Source
    • "The model used in this study (ASMED, Florence, Italy) is specific for regenerative treatment. REAC technology has demonstrated efficacy in ameliorating several stress-related disorders,7–13 depression,12,14,15 anxiety,12,15 social anxiety,16 agoraphobia,17 bipolar disorder,18 behavioral and psychiatric symptoms in Alzheimer’s disease,19 and impaired motor control.20–24 Recently, REAC technology using IVRTP has also demonstrated an ability to induce stem cell pluripotency and differentiation.25 "
    [Show abstract] [Hide abstract]
    ABSTRACT: Beta-galactosidase is the most widely used biomarker for highlighting the processes of cellular aging, including neurodegeneration. On this basis, we decided to test in vitro whether a set of rescuing/reparative events previously observed by us in subjects treated with radioelectric asymmetric conveyor (REAC) technology may also involve antagonism of a marker of aging-related degenerative processes, as assessed by a reduction in beta-galactosidase at the cellular level. Human adipose-derived stem cells were cultured at different passages, ranging from 5 to 20, with or without REAC exposure for 12 hours. The cells were then processed for biochemical beta-galactosidase staining and morphological microscopy analysis. We observed a significant reduction in expression of senescence associated-beta-galactosidase, and a persistence of fibroblast-like morphology typical of human adipose-derived stem cells, even at late passages. Our results indicate the ability of REAC technology to counteract in vitro senescence of human adipose-derived stem cells, and prompt the hypothesis that such technology may be exploited to antagonize in vivo senescence of tissue-resident or transplanted stem cells playing an important role in clinical treatment of age-related processes.
    Full-text · Article · Jun 2012 · Clinical Interventions in Aging
Show more